Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q2 2026)
2,073
Value
$37.3K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of SRPT by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,073$37.3K<0.1%−1,563−43.0%ReducedHolders
Q1 20263,636$79.1K<0.1%−768−17.4%ReducedHolders
Q4 20254,404$94.8K<0.1%+896+25.5%AddedHolders
Q3 20253,508$67.6K<0.1%−208−5.6%ReducedHolders
Q2 20253,716$63.5K<0.1%+543+17.1%AddedHolders
Q1 20253,173$202.5K<0.1%−573−15.3%ReducedHolders
Q4 20243,746$455.5K<0.1%−2,803−42.8%ReducedHolders
Q3 20246,549$817.9K<0.1%+271+4.3%AddedHolders
Q2 20246,278$991.9K<0.1%−2,137−25.4%ReducedHolders
Q1 20248,415$1.09M<0.1%+876+11.6%AddedHolders
Q4 20237,539$727.0K<0.1%+1,043+16.1%AddedHolders
Q3 20236,496$787.4K<0.1%−282−4.2%ReducedHolders
Q2 20236,778$776.2K<0.1%−2,099−23.6%ReducedHolders
Q1 20238,877$1.22M<0.1%+524+6.3%AddedHolders
Q4 20228,353$1.08M<0.1%−4,002−32.4%ReducedHolders
Q3 202212,355$1.36M<0.1%−40−0.3%ReducedHolders
Q2 202212,395$929.0K<0.1%+392+3.3%AddedHolders
Q1 202212,003$937.0K<0.1%−306−2.5%ReducedHolders
Q4 202112,309$1.11M<0.1%+1,519+14.1%AddedHolders
Q3 202110,790$998.0K<0.1%+566+5.5%AddedHolders
Q2 202110,224$795.0K<0.1%+1,350+15.2%AddedHolders
Q1 20218,874$663.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.